RxDoctor Payments Data

Irfan Altafullah

Neurology · Golden Valley, MNNPI 1437103629

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $197,792 of the $203,171 with a category attached, or 97.4%. Abbott accounts for 86.5% of it on its own, with 16 other manufacturers making up the rest. Among neurology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$203,171in general payments, 2019–2025

Across 223 payments — averaging $911.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$176K
  • MIVI Neuroscience, Inc.$13K
  • AstraZeneca$5K
  • Biosense Webster, Inc.$5K
  • Bayer$2K
  • Genentech, Inc.$1K
  • plus $2K from 11 others
$183,360in research payments, 2019–2025

Across 52 payments — averaging $3526.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$85K
  • Novartis$79K
  • Bayer$19K

What the payments were for

  • Consulting fees$197,79297%
  • Speaking & faculty fees$4,0002%
  • Travel & lodging$7720%
  • Food & beverage$6060%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott185$175,827
MIVI Neuroscience, Inc.4$12,700
AstraZeneca7$4,920
Biosense Webster, Inc.6$4,838
Bayer3$1,763
Genentech, Inc.1$1,380
Biogen1$930
Medtronic1$400
Intrafusion GP, LLC3$146
W. L. Gore & Associates, Inc.2$74
Silk Road Medical, Inc.1$57
GE HealthCare2$35
Sunovion Pharmaceuticals Inc.2$33
United Imaging Healthcare North America LLC1$25
Catalyst Pharmaceuticals, Inc.1$17
Eisai Inc.1$13
Genentech USA, Inc.2$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$203,171 in reported general payments places this provider in the 95th percentile of 434 neurology providers in Minnesota.

See all neurology providers in Minnesota

Medicare billing

Part B allowed, 2024
$104,001
Medicare patients
39
Services billed
1,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DilantinPhenytoin Sodium Extended13$5,903
Levetiracetam60$2,945
Mycophenolate Mofetil20$1,475
Selegiline Hcl11$1,411
Pyridostigmine Bromide25$834
Gabapentin20$570
Atorvastatin Calcium25$395
Duloxetine Hcl20$381
Lamotrigine13$283
Phenobarbital13$239
ClopidogrelClopidogrel Bisulfate11$145
Divalproex Sodium12$96
Prednisone31$90

Paid to pharmacies, not to this prescriber.

Other neurology in Golden Valley

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →